BrightInsight Patient Persistence Solution

BrightInsight, Inc. is a digital health company with its address at 333 W San Carlos Street, San Jose, California, according to its privacy policy; no founding year is stated on the site. It sells a patient persistence solution to biopharma and healthcare organizations that predicts and prevents therapy drop-off.

The solution unifies the patient experience across programs, detects behavioral signals that come before discontinuation and triggers interventions. The site also lists data and insights services and Software as a Medical Device (SaMD) offerings across cardiovascular, diabetes, immunology, mental health, oncology, rare disease and respiratory areas. A Sanofi case reports a 4% reduction in discontinuation.

• Persistence prediction: detects behavioral signals that precede discontinuation.
• Intervention triggers: starts targeted outreach when risk signals appear.
• Unified patient experience: personalized multi-modal experiences across programs.
• Data and insights: reporting on adherence and persistence outcomes.
• Software as a Medical Device: SaMD development for regulated digital therapeutics.
• Therapeutic coverage: cardiovascular, diabetes, immunology, mental health, oncology, rare disease and respiratory.

Multinational pharmaceutical firms with Vietnam operations could run persistence programs for diabetes or oncology drugs. Hospital groups could pilot app-based follow-up after treatment. Medical device makers could study the SaMD path for companion apps.

Predicts therapy drop-off so teams can act before patients stop treatment. A Sanofi case on the site reports a 4% reduction in discontinuation and a 4% gain in adherence over one year. Stanford Health Care reported more than 80% of macular disease patients still using the myVisionTrack app after a year. One platform unifies programs and interventions.

Pharma companies are shifting from one-off adherence reminders to predictive persistence programs, especially for chronic and specialty therapies. In Southeast Asia, growth of chronic disease and private healthcare creates a similar need, but the platform is oriented to biopharma customers and US-style program structures.

BrightInsight, Inc., San Jose, California (privacy policy). Customer and partner logos on the site include BioMarin, CSL, Roche, Sanofi, Google Cloud and FPT. A press release in May 2026 covered Stanford Health Care results. Founding year and certifications are not stated.